JPS6365047B2 - - Google Patents

Info

Publication number
JPS6365047B2
JPS6365047B2 JP56201934A JP20193481A JPS6365047B2 JP S6365047 B2 JPS6365047 B2 JP S6365047B2 JP 56201934 A JP56201934 A JP 56201934A JP 20193481 A JP20193481 A JP 20193481A JP S6365047 B2 JPS6365047 B2 JP S6365047B2
Authority
JP
Japan
Prior art keywords
acid
compound
injection
aspartic acid
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56201934A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58103312A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP56201934A priority Critical patent/JPS58103312A/ja
Priority to ES518199A priority patent/ES518199A0/es
Priority to PT75985A priority patent/PT75985B/pt
Priority to GR70069A priority patent/GR77823B/el
Priority to CA000417637A priority patent/CA1184495A/en
Priority to MX82101115U priority patent/MX7581E/es
Priority to KR8205621A priority patent/KR880001632B1/ko
Publication of JPS58103312A publication Critical patent/JPS58103312A/ja
Publication of JPS6365047B2 publication Critical patent/JPS6365047B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56201934A 1981-12-15 1981-12-15 難溶性医薬品の注射剤用水溶液 Granted JPS58103312A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP56201934A JPS58103312A (ja) 1981-12-15 1981-12-15 難溶性医薬品の注射剤用水溶液
ES518199A ES518199A0 (es) 1981-12-15 1982-12-14 Un procedimiento para producir una composicion inyectable acuosa de famotidina.
PT75985A PT75985B (en) 1981-12-15 1982-12-14 Process to produce a pharmaceutical composition of famotidine for injection
GR70069A GR77823B (enExample) 1981-12-15 1982-12-14
CA000417637A CA1184495A (en) 1981-12-15 1982-12-14 Process of producing pharmaceutical composition of famotidine for injection
MX82101115U MX7581E (es) 1981-12-15 1982-12-15 Procedimiento para preparar una composicion farmaceutica a base de famotidina
KR8205621A KR880001632B1 (en) 1981-12-15 1982-12-15 Process for preparing famotidino injection composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56201934A JPS58103312A (ja) 1981-12-15 1981-12-15 難溶性医薬品の注射剤用水溶液

Publications (2)

Publication Number Publication Date
JPS58103312A JPS58103312A (ja) 1983-06-20
JPS6365047B2 true JPS6365047B2 (enExample) 1988-12-14

Family

ID=16449204

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56201934A Granted JPS58103312A (ja) 1981-12-15 1981-12-15 難溶性医薬品の注射剤用水溶液

Country Status (7)

Country Link
JP (1) JPS58103312A (enExample)
KR (1) KR880001632B1 (enExample)
CA (1) CA1184495A (enExample)
ES (1) ES518199A0 (enExample)
GR (1) GR77823B (enExample)
MX (1) MX7581E (enExample)
PT (1) PT75985B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002322057A (ja) * 2001-04-27 2002-11-08 Terumo Corp ファモチジン注射液

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8703865A2 (es) * 1985-06-28 1987-03-16 Barisintex Sa Perfeccionamientos en la patente de invencion n.544661 por: procedimiento de preparazcion de ascorbatos antagonistas h2-receptores.
EP1336408A4 (en) * 2000-11-24 2005-01-19 Yamanouchi Pharma Co Ltd WATER-SOLVENT LIQUID MEDICAMENT FOR INHALATION
JP3648531B2 (ja) 2000-12-22 2005-05-18 山之内製薬株式会社 ファモチジン注射液
JP4374250B2 (ja) * 2001-12-27 2009-12-02 テルモ株式会社 ファモチジン注射液
EP1504755A1 (en) * 2002-05-13 2005-02-09 Daiichi Pharmaceutical Co., Ltd. Lyophilization product
CN111904936B (zh) * 2020-08-28 2022-07-19 开封康诺药业有限公司 一种法莫替丁冻干粉针剂
CN114681409A (zh) * 2021-10-20 2022-07-01 海南倍特药业有限公司 一种注射用法莫替丁及其制备方法
CN114028342B (zh) * 2021-12-08 2023-04-28 广东彼迪药业有限公司 一种法莫替丁速崩颗粒、法莫替丁片及制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002322057A (ja) * 2001-04-27 2002-11-08 Terumo Corp ファモチジン注射液

Also Published As

Publication number Publication date
MX7581E (es) 1989-11-24
ES8405613A1 (es) 1984-06-16
PT75985A (en) 1983-01-01
CA1184495A (en) 1985-03-26
KR880001632B1 (en) 1988-09-03
PT75985B (en) 1985-12-05
GR77823B (enExample) 1984-09-25
ES518199A0 (es) 1984-06-16
KR840002654A (ko) 1984-07-16
JPS58103312A (ja) 1983-06-20

Similar Documents

Publication Publication Date Title
US4018889A (en) Oxytetracycline compositions
JPS6191116A (ja) 安定化された注射用ピロキシカム液剤
JPS6365047B2 (enExample)
IE57905B1 (en) Solutions of lactic acid salts of piperazinylquinolone-an piperazinyl-azaquinolone-carboxylic acids
DK157731B (da) Stabile pharmaceutiske praeparater indeholdende oxicamderivater og fremgangsmaade til fremstilling heraf
WO2003033026A1 (en) Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent
JPS625975A (ja) フロセミド誘導体
JPH0840907A (ja) セファロスポリン注射剤
JPH07503941A (ja) スパルフロキサシンの溶液、その調製及びそれから成る塩
US2407412A (en) Therapeutic solutions
JPH11266844A5 (enExample)
CA1170571A (en) Pharmaceutical compositions
JP3213283B2 (ja) 注射剤
JP2004509921A (ja) 酸含有量が少ない保存安定性のあるシプロフロキサシンの輸液
KR920006911B1 (ko) 안정한 피록시캄 주사액 조성물 및 그의 제조방법
JPWO2002092092A1 (ja) ミノキシジル配合液剤組成物
US4377583A (en) N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid
US5290794A (en) Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
US5554618A (en) Intravenously administrable aqueous solution
JP2002322057A (ja) ファモチジン注射液
JPH0118051B2 (enExample)
US3865940A (en) Pharmaceutical preparation
JPH11193234A (ja) ニカルジピンの液状医薬品製剤
KR20030044522A (ko) 파모티딘 주사용 액제 조성물
JPS6229421B2 (enExample)